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Fabrication of nanofibres using bioinspired
microfluidic spinning
The fabrication of micro- and nanoscale fibres have garnered a
lot of attention within the biomedical engineering community
due to their diverse applications in the field of tissue
engineering and regenerative medicine.1 With their unique
nanotopography and biomimetic architecture, fibres present a
platform akin to the native extracellular matrix (ECM)
environment and allow better control of the cellular behavior
(such as attachment, proliferation and differentiation). In
recent years, several methods have been introduced to produce
different types of biocompatible fibres in a continuous
manner. These approaches include electrospinning and
microfluidic spinning, which generate fibres with a homo-
genous chemical composition. However, these technologies
are not easily adaptable to generate highly ordered and stable
fibres with variable dimensions. To develop an ECM-mimick-
ing scaffold, it is important to have a technology that can
fabricate fibres with controlled structural features in a
continuous manner.2
Inspired by the spinning mechanism of a silkworm, Lee
and colleagues3 have recently developed a strategy to generate
fibres with tunable morphological and biofunctional proper-
ties. To demonstrate their approach, Chae et al.3 used a non-
toxic polysaccharide, alginate, as the model polymer. The
schematic illustrations in Fig. 1a and b demonstrate the
spinning duct of a silkworm where the fibroin protein is first
produced at the posterior division, then gradually transferred
to the middle division where the fibroin solution is concen-
trated to form micelle-like globular aggregates. These aggre-
gates become oriented and stretched due to the physical
shearing effects in the narrow duct. Finally, crystallization
induces silk fibre formation from the globular protein
structures due to the combined effect of shear stress and
dehydration of the aqueous phase in the anterior portion of
the spinning duct.
Mimicking the natural fibre spinning procedure of the
silkworm, a fibre spinning microfluidic device was devised
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Fig. 1 (a) Schematic illustration of a silkworm’s spinning duct. (b) Basic
mechanism of dehydration process of aqueous ionic polymer to form
aggregates, eventually leading to nanostrands and highly ordered crystalline
fibre formation due to shear stress. (c) The microfluidic system, mimicking the
silkworm’s spinning duct, consisting of two inlet channels and one outlet
channel, with a core aqueous alginate and an outer IPA sheath flow. Scanning
electron microscope images of nanofibres with different dimensions and
morphologies (d, e, and f). Figure adapted and reprinted with permission from
Chae et al.3
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that consisted of two inlet and one outlet channels (Fig. 1c).
The main microchannel had an initial width of 100 mm which
tapered to an intersection point with a 30 mm width. Aqueous
alginate prepolymer solution was used as the core fluid stream
surrounding the flow to initiate the spinning process and
water-miscible isopropyl alcohol (IPA) solvent was used as the
sheath fluid at the junction. IPA has low polarity and can
induce aggregate formation of ionic polymers, such as
alginate, due to the dipole–dipole attractions at the dehydrat-
ing interface between the aqueous alginate core and the outer
IPA sheath fluid.
Thus, as the dehydration by the IPA flow gradually
progressed towards the core alginate flow, the alginate
polymer chains aggregated towards the outlet, similar to the
micelle-like fibroin globular aggregate formation at the
anterior end of the silkworm’s spinning duct. The shear force
on the aggregates inside the microchannel helped to form
densely packed and aligned nanostrands, eventually leading to
the generation of highly ordered, mechanically strong alginate
fibres with varying dimensions. By adjusting the flow rate of
IPA and alginate in the microchannels, highly compact fibres
with different geometries such as cylindrical, semi-cylindrical,
seaweed-like and ultrathin structures were obtained.
Additionally, the study demonstrated the generation of fibres
with different dimensions through a single misaligned
microchannel using the principle of Kelvin–Helmholtz
instabilities which occur as a function of interfacial tension
between the miscible fluids with different densities and
velocities. Moreover, by varying the flow rates in the
misaligned microchannel, multiple fibres with diverse
morphologies were obtained.
These alginate nanofibres can be particularly useful to
fabricate scaffolds which possess biomechanical functionality
and strength to deliver sustainable micro-strains to cells and
tissues.4 Moreover, the free carboxylic acids on the alginate
polymer backbone can be chemically modified with functional
peptide molecules to promote cell-alginate interactions.
Magnetically controlled rare cell isolation
and release
The isolation of rare cells from blood has numerous
biomedical applications. For instance, cell sorting can be
used to isolate circulating tumor cells, detect viruses and
diagnose prenatal disorders.5 Typical cell sorting techniques,
such as flow cytometry and immobilizing binding agents on
microfluidic device surfaces, have their respective drawbacks
of being inefficient or lacking cell release mechanisms.6
Recently, Zhao and colleagues have developed a simple
microfluidic device that uses magnetic nanoparticles (MNPs)
for the capture and release of rare circulating cells.7
In their recent paper, Yu et al.7 demonstrated an efficient
capture and release strategy using magnetic fields. First, they
fabricated nickel micropillar columns inside a microfluidic
channel (Fig. 2). To create the MNPs, Fe3O4 nanoparticles were
embedded in graphene oxide (GO) sheets by solution mixing.
GO was chosen for its high stability and biocompatibility.
Carboxyl groups on the GO-Fe3O4 sheets were activated and
conjugated with streptavidin, a molecule with high affinity to
biotin. In this state the GO-Fe3O4 sheets were primed for
functionalization with biotinylated antibodies specific to the
cells under investigation. Two permanent magnets were
placed on either side of the microchannel generating a
magnetic field perpendicular to the flow. Magnetic flux density
was calculated to be largest near the top and the bottom of the
pillars parallel to the magnetic field and was confirmed by
running fluorescent MNPs through the device. The fluorescent
MNPs were trapped at the upper and lower regions around
each micropillar parallel to the magnetic field. Turning off the
magnetic field was able to release the MNPs from their trapped
sites.
To test their device, the authors designed an experiment to
determine the device’s capture efficiency of rare cells
suspended in a medium. HCT116 colorectal cancer cells were
chosen because they overexpress an antigen called epithelial
cell adhesion molecule (EpCAM). GO-Fe3O4 MNPs (GO-F)
sheets conjugated with streptavidin were incubated with
biotinylated anti-EpCAM so that the cells in transit expressing
EpCAM were attracted to the MNPs via cell affinity. The anti-
EpCAM-MNPs were suspended in a PBS solution, injected into
the device and the magnetic field was applied. The HCT116
cells were next suspended in a culture medium, injected into
the device and the captured cells were inspected by a
microscope. To release the captured cells, the magnetic field
was turned off and the device was washed with PBS. The
microfluidic device exhibited a capture rate .70% for the
HCT116 cells in the medium. The device’s capture rate was
enhanced by the clever design of the interaction between the
cells and the micropillars via the use of high density GO-Fe3O4
binding sites.
Fig. 2 (a) Diagram of the microfluidic device decorated with nickel micropillars
during cancer cell assay. (b) Schematic of a cancer cell binding to magnetic
nanoparticles on a micropillar. (c) Image of a cancer cell binding to a micropillar
during an actual experiment. Figure adapted and reprinted with permission
from Yu et al.7
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The efficiency of the device was based on three key factors:
pillar diameter, pillar height and flow rate. The optimal pillar
diameter was experimentally determined to be 50 mm.
Micropillar heights were controlled simply by adjusting the
electroplating times. Capture efficiencies rose with increasing
micropillar heights of up to 10 mm and then reached a
saturation point. Yu et al.7 surmised that this observation was
due to both the average diameter of the cancer cells being 8–10
mm and the cancer cells precipitating to the bottom of
microchannel. Since the cancer cells were about the same
height as the micropillars and the MNPs were distributed to
the top and bottom of the micropillars, the cancer cells were
able to bind to the MNPs on both the top and the bottom
maximizing capture efficiency. A flow rate of 50 mL h21 or
below was found to be optimal as the cells precipitated to the
bottom of the channel at this flow rate. Capture efficiency was
significantly decreased at flow rates above 100 mL h21 due to
the reduced interactions between the cells and the micro-
pillars.
A unique aspect of this device is the ease in releasing the
captured cells. By removing the permanent magnets and
washing the sample with PBS, the MNP-cancer cells were
readily released from the micropillars. About 93% of the
captured cells were released while some cells remained
trapped by the residual magnetic flux density in the nickel
micropillars. The released cells had a high viability of about
78% as confirmed by the fluorescein diacetate and propidium
iodide staining (a probe that measures enzyme activity and cell
viability). Additionally, even with the MNPs still attached to the
cells, the analysis of the cellular DNA and RNA content can still
proceed. This reusable device offers an affordable and
advantageous alternative to traditional cell sorting and will
inspire new applications in diagnostics, therapeutics and
biotechnology.
Modular microfluidic systems using PDMS
control valves
Microfluidic systems enable the manipulation of fluids
generally in a highly accurate way in very small volumes,
often at the nanoliter scale. The application of microfluidic
technologies for high-throughput studies as well as the
development of new analytical devices have led to the design
and fabrication of sophisticated systems.8 Proper control of
fluid movements in these systems has required significant
technological efforts.9 For example, monolithic PDMS micro-
mechanical valves, are popular and attractive due to their ease
of fabrication, low cost and scalability. These valves have
found applications in several fields, such as protein crystal-
lography, genetic analysis, high-throughput screening, and
chemical synthesis.9 Recent technological advances have led to
the development of microfluidic very large scale integration
(mVLSI) with an astonishing number of integrated valves
(thousands of valves per cm2).8
On the other hand, modular systems represent an interest-
ing alternative to the large scale integration approach. By
fabricating and assembling modular elements, complex
systems can be created without the need for redesigning
and/or refabricating the entire microfluidic system (a crucial
point during the prototyping phase). To create modular
systems, an important challenge is the development of hybrid
systems which allow reversible bonding between different
devices with a standardized interconnection scheme. Recently,
Skafte-Pedersen et al.10 reported a modular hybrid system with
a universal soft lithography-based fluidic control module
interfaced to an external hard polymeric chip. This system
consisted of different modular elements (Fig. 3): i) a three-
layer PDMS-based fluidic control module fabricated by soft
lithography and controlled pneumatically; ii) a hard passive
PMMA chip, having a 2D chamber with 4 6 8 interconnec-
tions; iii) a polycarbonate clamping system as the mechanical
support to the chip-to-control module interconnection, that
assures very small variations in the flow rate with no leaks. The
system is completed by integrating O-rings, enabling the
control of module-hard chip fluidic interconnections and
allowing the reversible sealing of the elements. The platform
offers a robust flow control in two dimensions using external
PDMS valves in a fully passive microfluidic PMMA chip, as
demonstrated with complex on-chip fluid patterns through the
2D chamber. Interestingly, the authors showed that the
assembly of several elements does not affect the performance
in terms of flow stability as the O-ring-based interconnection
scheme provided robust sealing of the overall platform.
Though currently simpler than the high density microscale
integrated systems present in the literature (lower valve
density in comparison to monolithic systems), this approach
presents an interesting modular concept and an interconnec-
tion scheme and can be the starting point for the generation of
Fig. 3 Schematic of the modular hybrid microfluidic system. (a) Expanded view
showing the passive PMMA chip, the PDMS fluid control module and the
clamps. (b) The cross-sectional view of the system. (c) Images of the modular
hybrid microfluidic systems. Figure adapted and reprinted with permission from
Skafte-Pedersen et al.10
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more complex microfluidic devices. Moreover, a variety of
different applications can potentially be envisioned for these
systems, thanks to their flexibility in terms of materials,
integratable elements and configurations.
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